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2014; doi:10.1152/japplphysiol.00793.2014.—Sepsis and sepsis-associ-
ated multiorgan failure represent the major cause of mortality in
intensive care units worldwide. Cardiovascular dysfunction, a key
component of sepsis pathogenesis, has received much research inter-
est, although research translatability remains severely limited. There
is a critical need for more comprehensive preclinical sepsis models,
with more clinically relevant end points, such as microvascular
perfusion. The purpose of this study was to compare microcirculatory
blood flow measurements, using a novel application of laser speckle
contrast imaging technology, with more traditional hemodynamic end
points, as part of a multiparameter monitoring system in preclinical
models of sepsis. Our aim, in measuring mesenteric blood flow, was
to increase the prognostic sensitivity of preclinical studies. In two
commonly used sepsis models (cecal ligation and puncture, and
lipopolysaccharide), we demonstrate that blood pressure and cardiac
output are compromised postsepsis, but subsequently stabilize over
the 24-h recording period. In contrast, mesenteric blood flow contin-
uously declines in a time-dependent manner and in parallel with the
development of metabolic acidosis and organ dysfunction. Impor-
tantly, these microcirculatory perturbations are reversed by fluid
resuscitation, a mainstay intervention associated with improved out-
come in patients. These data suggest that global hemodynamics are
maintained at the expense of the microcirculation and are, therefore,
not sufficiently predictive of outcome. We demonstrate that microcir-
culatory blood flow is a more sensitive biomarker of sepsis syndrome
progression and believe that incorporation of this biomarker into
preclinical models will facilitate sophisticated proof-of-concept stud-
ies for novel sepsis interventions, providing more robust data on
which to base future clinical trials.
animal models of cardiovascular disease; microcirculation; sepsis;
septic shock
SEPSIS IS AN OVERWHELMING systemic inflammatory response to
infection that can progress to severe sepsis and, ultimately,
septic shock, characterized by cardiovascular dysfunction, re-
fractory hypotension, and insufficient organ perfusion. Despite
decades of research, sepsis continues to be a significant clinical
problem, accounting for an estimated 215,000 deaths per an-
num in the USA alone (2).
Historically, the treatment of patients with severe sepsis in
critical care units has focused on achieving a target blood
pressure and cardiac output (CO) and normalizing global
circulatory parameters. In recent years, it has become increas-
ingly clear that systemic stabilization does not necessarily
prevent the onset of organ failure and may actually occur at the
expense of microcirculatory perfusion (43, 45). Indeed, persis-
tently diminished microcirculatory flow in patients with re-
stored blood pressure and cardiac function is associated with
organ failure and poor outcome (43). While clinical studies
have demonstrated a strong association between microcircula-
tory perfusion and outcome (15), and microvascular monitor-
ing is increasingly used as a research tool in the clinic (14),
preclinical models rarely assess this parameter. This may have
contributed to the subsequent failure in clinical trials of nu-
merous promising preclinical leads.
Sepsis and septic shock are commonly modeled in rodents
by systemic administration of a bacterial endotoxin, or through
puncture of the cecum to induce polymicrobial peritonitis (40).
These models produce pathophysiological alterations similar to
those encountered in patients (a profound inflammatory re-
sponse with disrupted thermoregulation and cardiovascular
function). Nonetheless, they are widely criticized for their
limitations and propensity to generate promising therapies that
have later failed in clinical trials (38). This poor clinical
translatability may, in part, arise from inadequacies in the
prognostic value of measured end points. Indeed while sys-
temic hemodynamics are routinely monitored in preclinical
models of sepsis and septic shock, these parameters do not
sufficiently predict the onset of organ failure (1, 52), the
ultimate cause of death in patients (15).
Shunting of blood flow away from compliant tissues (those
supplied by the splanchnic circulation, for example) to main-
tain perfusion of the brain and heart is thought to occur in
sepsis (22, 36). While initially adaptive, prolonged regional
ischemia can become maladaptive, since poor intestinal perfu-
sion, known clinically as the “motor of organ failure” (7), can
actually exacerbate systemic inflammation by facilitating
breakdown of intestinal barriers (44). Correspondingly, gastric
tonometry and sublingual blood flow have previously been
used as clinical tools to ascertain patient prognosis and evalu-
ate the response to therapeutic interventions (37, 48).
Given that splanchnic perfusion can be used clinically as an
indicator of syndrome progression, it would seem prudent to
assess this parameter during preclinical experimentation. Fur-
thermore, a greater understanding of microcirculatory distur-
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bances in sepsis may help to guide therapeutic intervention.
Indeed, it is known that patients become resistant to catechol-
amine vasopressor treatment, and prolonged use of such agents
may worsen outcome (17). Similarly, many vasoactive agents
have divergent effects in macrocirculatory vs. microcirculatory
beds (18), and hence empirical measures of both, taken in
parallel as the sepsis syndrome progresses, seem essential both
for preclinical studies, to validate new drug targets, and for the
clinical management of sepsis patients.
We have developed and validated a novel approach to
assessing microcirculatory perfusion in septic mice and have
used this in conjunction with traditional measures of global
circulatory hemodynamics, locomotor activity, thermoregula-
tion, cardiac function, and blood biochemistry. We present data
from two widely used models of sepsis where we compare and
describe, in absolute terms, the observed pathophysiological
changes at all levels of the cardiovascular system in a single
mouse. Our multiparameter monitoring system facilitates
paired analysis, where each animal acts as its own control,
maximizing the data generated, while minimizing stress-in-
duced artifacts. This has allowed us to investigate the prog-
nostic value of different cardiovascular parameters. We dem-
onstrate that, while macrocirculatory hemodynamics stabilize
during the course of the sepsis syndrome development, it is
microcirculatory perfusion that more closely correlates with
markers of end-organ damage and metabolic acidosis.
METHODS
All animal experiments were conducted under a UK Home Office
license, following local ethics committee approval and in accordance
with the Home Office Animal (Scientific Procedures) Act, 1986.
Experiments were designed and conducted in a blinded manner and in
accord with the ARRIVE (Animal Research: Reporting of In Vivo
Experiments) guidelines (30).
Murine models of septic shock. Male C57BL/6 mice were bred in
house and given access to food and water ad libitum. Sepsis was
induced under brief anesthesia (2% isoflurane; by air pump). Endo-
toxemia was induced by intravenous injection into the tail vein of
lipopolysaccharide (LPS; 12.5 mg/kg) from Salmonella typhimurium
(Sigma, L7261). Polymicrobial peritonitis was induced by cecal
ligation and puncture (CLP), as described previously (40). Briefly, the
cecum was externalized through a midline laparotomy, then ligated
and punctured through and through with a 19-gauge needle. Slight
pressure was applied to extrude a single droplet of fecal matter from
each of the two puncture sites. In control sham-operated animals,
laparotomy and exteriorization were performed without ligation and
puncture. Incisions were closed with 5.0 Vicryl sutures, and saline
resuscitation (0.9%; 40 ml/kg sc) was given. Buprenorphine hydro-
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Fig. 1. Assessment of systemic hemodynamics and loco-
motor activity in the same mice under naive and septic
conditions. Mean arterial pressure (MAP; A), heart rate (B),
and locomotor activity (C), before and after induction of
sepsis [at time 0: lipopolysaccharide (LPS), 12.5 mg/kg, or
cecal ligation and puncture (CLP)] or sham procedures are
shown. Boxed regions denote periods of darkness. Data
were acquired by radiotelemetry in conscious, ambulatory
male C57BL/6 mice and are presented as means SE; n
6–11. bpm, Beats/min.
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chloride (15 g/kg im; Vetergesic; Alstoe Animal Health, UK) was
administered to provide postoperative analgesia.
Implantation of radiotelemeters and hemodynamic measurements.
PA-C10 radiotelemeter devices (Data Sciences International; DSI)
were implanted in 10-wk-old mice under isoflurane anesthesia (2% by
air pump). Mice were kept on a homeothermic heating blanket
(Harvard Instruments) with eye protection (Viscotears). The surgical
field was sterilized with chlorhexidine, and buprenorphine hydrochlo-
ride (15 g/kg im) was administered to provide postoperative anal-
gesia. Telemeter catheters were implanted into the left carotid artery
of naive mice and advanced toward the aortic arch. The body of the
transmitter was placed in a subcutaneous pocket in the left flank,
equidistant between the fore- and hindlimb. The incision was closed
with 5.0 Vicryl sutures. Saline resuscitation (0.9%; 40 ml/kg sc) was
administered, and animals were placed in a recovery cabinet at 28°C
for 4 h. Animals were allowed to recover at room temperature for 10
days before recording of baseline parameters over 48 h. Sepsis was
then induced as described above, and recordings were taken over a
further 24 h. Animals exhibiting a dampening of the hemodynamic
profile were excluded from analysis. Radiotelemetry devices allow
continuous remote recording of blood pressure waveforms and cage
activity. Data were acquired continuously at 25 Hz using standard
acquisition software (DSI).
Evaluation of cardiac performance by echocardiography. Left
ventricular (LV) function and chamber dimension were determined in
vivo by echocardiography under isoflurane anesthesia. Mice were
placed in a supine position on a homeothermically controlled table,
and limb leads were attached for electrocardiogram gating. Images
were acquired in the left lateral decubitus position with a 30-MHz
linear probe (Visualsonic Vevo 770, 30-MHz linear signal trans-
ducer). Two-dimensional images in parasternal long- and short-axis
projections were recorded with guided M-mode recordings at the
midventricular level in both views. Interventricular, septal, and LV
posterior wall dimensions were taken in diastole and systole, in
addition to LV internal dimensions.
Evaluation of blood flow by laser speckle contrast imaging. Blood
flow was recorded in the mesenteric vasculature and the ear, using a
moorFLPI full-field laser perfusion imaging system and review soft-
ware (Moor Instruments, Devon, UK), either in control animals, or at
various time points after the induction of sepsis (6 or 24 h post-LPS
or post-CLP).
Mice were anesthetized under isoflurane (2% by air pump), and
core temperature was recorded and controlled by a rectal probe
coupled to a homeothermic heating mat. For mesenteric blood flow
measurements, mice were laid on their side, hair was removed from
the abdomen by electrical shaver, and a small midline incision was
made. A portion of the small intestine was gently exteriorized onto a
parafilm-coated heating mat and was pinned out through the gut wall
to expose the mesenteric vasculature (see Fig. 2A). Care was taken not
to stretch or puncture blood vessels, and, if excessive bleeding was
observed, mice were terminated immediately and excluded from
analysis (7%). The exposed vascular bed was kept moist with saline
(0.5 ml aerosolized) prewarmed to 37°C. For ear measurements, mice
were placed in the prone position. The laser was positioned 25 cm
above the region of interest, and zoom and focus were adjusted
appropriately to acquire high-resolution images of the ear or mesen-
tery (see Fig. 2A). No further investigator intervention or microdis-
section was necessary.
The following acquisition modes and settings were used: high-
resolution capture (25 frames, 1 s/frame); exposure 20 ms; automatic
gain; flux palette set at 0–5,000 for mesentery, and 0–1,000 for ear;
background threshold 60 flux units. Flux over time was analyzed
offline by moorFLPI Review software (V3; Moor Instruments, Devon,
UK) and branches of the mesenteric vascular tree were designated as
first-, second-, or third-order vessels. Regions of interest in which flux
over time was measured were defined in each visible vessel, and a
mean value was obtained for each level of mesenteric branching in
each vascular bed. All assessment and analysis were performed in a
blinded manner.
This system is based on the random speckle patterns produced
when tissue is illuminated by laser light. In regions of high blood flow,
the speckle pattern generated by moving red blood cells becomes
blurred, reducing contrast in that region. Correspondingly, high-
contrast speckle patterns are associated with low flow. Automated
processing of the contrast images generates real-time, high-resolution,
color-coded flux images, which correlate with blood flow in each
region (6).
Table 1. Statistical comparison of hemodynamic data obtained by radiotelemetry
Mean Arterial Pressure, mmHg Heart Rate, beats/min
Mean (CI) df P value Mean (CI) df P value
Difference naive-CLP 11 (5 to 17) 10 0.003* 21 (79 to 37) 10 0.4425
Difference naive-LPS 37 (25 to 49) 9 0.0001† 112 (64 to 161) 9 0.007*
Difference naive-sham 11 (27 to 4) 4 0.1122 34 (23 to 45) 4 0.0009†
Difference sham-CLP 28 (16 to 41) 24 0.0002† 30 (79 to 20) 24 0.2316
Values are the difference in parameter estimates for the mean [with 95% confidence interval (CI) in parentheses], with degrees of freedom (df) over a 24-h
period (either before or following sepsis or sham surgery); n  6–11 mice. Values correspond to graphical data depicted in Fig. 1. CLP, cecal ligation and
puncture; LPS, lipopolysaccharide. *P  0.01 and †P  0.001, paired or unpaired two-tailed Student t-test.
Table 2. Cardiac function before and after induction of sepsis
Sham 6-h CLP 24-h CLP Naive 6-h LPS 24-h LPS
Cardiac output, ml/min 27.2 1.5 19.7  1.5† 18.3  1.6‡ 32.9  1.4 22.0  1.9‡ 22.0  1.1‡
Stroke volume, l 49.6 2.5 38.8  3.7* 26.7  3.9* 60.0  2.5 44.9  4.9* 43.7  1.3*
End-diastolic left ventricular volume, l 78.8  5.2 59.1  5.8 48.8  6.2† 94.3  3.6 116.1 9.1 77.7  9.4
Ejection fraction, % 63.8 2.4 66.2  2.7 77.4  3.3* 63.4  2.4 39.5  2.0‡ 57.1  6.4
Fractional shortening, % 34.6 1.8 36.2  2.1 46.4  3.5† 34.5  1.8 19.3  1.1† 30.6  4.3
Aortic flow, mm/s 1438  82 1337  98 1152  63 1519  56 808  36‡ 1136  97*
Values are means  SE, n  6–8 mice. Cardiac function was recorded by echocardiography (Vevo 770) in homeothermically heated (to 36°C), unconscious
(1.8% isofluorane) naive and sham-operated animals, and 6 and 24 h post-LPS and post-CLP. *P 0.05, †P 0.01, ‡P 0.001 relative to sham/naive, one-way
ANOVA  Bonferroni post hoc test.
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Blood biochemistry. Following mesenteric blood flow recording, a
venous blood sample was drawn from the inferior vena cava. Blood
biochemistry was assessed immediately from 100-l venous blood
using a hand-held iSTAT point-of-care analyzer (Abbott Laborato-
ries), with CG8 cartridges (Abbott Laboratories). The remaining
blood was centrifuged for isolation of the plasma fraction and snap-
frozen for future analysis. Animals were terminated by cervical
dislocation, and organs were harvested and snap-frozen for future
biochemical analysis.
Assessment of clinical relevance. In a separate series of experi-
ments, the impact of two mainstay clinical interventions on microcir-
culatory blood flow was assessed. Following CLP surgery, animals
were randomized to receive either no intervention, or Hartmann’s
solution containing 5% dextrose (40 ml/kg sc) at 0, 3, 6, and 18 h
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Fig. 2. Assessment of mesenteric blood flow in healthy and septic mice. A: experimental setup involving exteriorization of a section of the small intestine through
a small abdominal incision and careful pinning through the gut wall to expose the mesenteric vascular bed. Mice were placed on a parafilm-coated homeothermic
blanket coupled to a rectal temperature probe. The exposed mesenteric bed was moistened with prewarmed aerosolized saline solution. B: core body temperature
measured by rectal probe during baseline blood flow recording in naive and sham-operated animals and at 6 and 24 h post-LPS and -CLP (means  SE; n 
10–21). C: representative flux images taken during baseline recording. Cold colors indicate low flow; warmer colors higher flow. Mesenteric blood flow is
expressed as total area under the curve (AUC; 	103 flux units/time) over 5-min baseline recording in first (D), second (E), and third-order vessels (F), in naive
and sham-operated animals and 6 and 24 h post-LPS and -CLP. AUC for each animal is represented as an individual symbol, with mean for each group denoted
by a horizontal line. *P 0.05, **P 0.01, ***P 0.001 relative to naive/sham, and #P 0.05, ###P 0.001 relative to 6 h (one-way ANOVA Bonferroni
post hoc test).
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postsepsis, based on a regimen known to attenuate mortality in septic
mice (51). This fluid, similar to lactated Ringer’s solution, is a
crystalloid compound sodium lactate solution that is closely isotonic
with blood and is frequently used in the intensive care unit. In
LPS-treated mice, an intravenous catheter was introduced into the left
jugular vein under isoflurane anesthesia (2% by air pump) immedi-
ately before blood flow measurement. After a 5-min baseline record-
ing, a bolus dose of saline (100 l over 10 s) was administered
intravenously, followed 5 min later by a bolus dose of norepinephrine
bitartrate (30 g/kg in saline; 100 l over 10 s).
The impact of a topical vasodilator was also assessed in LPS-
treated mice, to determine reversibility of mesenteric flow perturba-
tions. Sodium nitroprusside (10 M in saline) was administered to the
mesentery as an aerosolized spray (200 l from a distance of 10 cm)
after 5-min baseline recording.
All administered solutions were prewarmed to 37°C before admin-
istration.
Microcirculatory blood flow and blood biochemistry were assessed
as described above. All studies were conducted in a blinded manner,
and investigators were unblinded to treatment group following data
analysis.
Statistical analysis. Data are represented as means  SE from n
number of mice, unless otherwise indicated. Data were assessed for
normality of distribution, and statistical comparisons of means were
performed using a Student’s t-test, or an ANOVA, as appropriate.
Results were considered statistically significant when P  0.05. Data
were analyzed using GraphPad Prism 5.0 or SPSS v.21 software.
RESULTS
Assessment of systemic hemodynamics by radiotelemetry.
Before the induction of sepsis, mean arterial pressure (MAP)
and heart rate (HR) exhibited normal diurnal variation, within
the expected physiological range for mice (12), and data were
fitted to a sine-wave function describing diurnal variation (Fig.
1, A and B, left) (5). Following the induction of sepsis, the
diurnal variation was lost, and data were consequently fitted to
a sine wave with exponential function (Fig. 1, A and B, right).
Diurnal variation in locomotor activity was also lost following
the induction of sepsis (Fig. 1C).
A paired comparison revealed a significant difference in
MAP between the naive and septic states for both CLP- and
LPS-treated mice (Table 1). A separate cohort of sham-oper-
ated mice was included to determine the impact of laparotomy
on diurnal hemodynamics and activity and to be used as a
surgical control for CLP-treated animals. MAP following CLP
was significantly reduced relative to sham-operated controls,
while no significant difference in MAP was detected between
paired naive and sham states (Table 1). The same pattern of
statistically significant change was observed for both systolic
and diastolic blood pressures in septic mice, but not in sham-
operated animals (data not shown).
While LPS-treated mice became steadily more hypoten-
sive postsepsis, mice subjected to CLP showed a more
gradual decrease in MAP that was less marked than in the
LPS model (Fig. 1A). This may be explained by the accel-
erated nature of the LPS model, which bypasses bacterial
processing and opsonization steps and is consistent with
previous hemodynamic assessments in murine endotoxemia
(39). In both models, however, MAP was found to stabilize
after 9 h postsepsis, a phenomenon that was not attributable
to nocturnal increases in locomotor activity (as this was
dramatically and persistently reduced as of 4 h postsepsis;
Fig. 1C) and was, therefore, likely the result of compensa-
tory cardiovascular changes.
Consistent with a decline in blood pressure, a transient
period of tachycardia was observed in both models of sepsis
(Fig. 1B). This reflex was subsequently lost in LPS-treated
mice, which went on to develop a significant reduction in HR
relative to the paired naive state (Table 1). In contrast, CLP-
treated mice did not exhibit a significantly altered HR, relative
to the paired naive state, and no significant difference in HR
was detected between sham- and CLP-operated mice (Table 1).
Sham surgery caused a transient decline in HR, consistent with
the stress-induced hypertension (Fig. 1A), suggesting an intact
baroreceptor reflex in these mice (Fig. 1B).
Assessment of cardiac function by echocardiography. Car-
diac function was measured in anesthetized telemetered mice
before and after the induction of sepsis. In both models of
sepsis, CO and stroke volume were found to decline initially,
indicating impaired cardiac function as of 6 h, consistent with
previous reports (27, 29, 51) (Table 2). Neither the presence of
a telemetry probe during echocardiographic recording, nor the
induction of anesthesia and echocardiographic monitoring in
telemetered mice was found to alter the hemodynamic profile
relative to uninstrumented mice or previous reports (27, 29, 35,
46, 50, 51), suggesting that both techniques can be used in
concert without mutual interference.
Table 3. Blood biochemistry in healthy and septic mice
Sham 6-h CLP 24-h CLP Naive 6-h LPS 24-h LPS
Creatinine, mol/l 18 0.0 18  0.0 36.5 29.3* 18 0.0 18  0.0 40.18 14.8*
Urea, mmol/l 4.79  0.29 6.08  0.67 17.03 4.26 4.57 0.37 8.10  1.45 36.47 2.89‡§
pH 7.29  0.01 7.23  0.02 7.15  0.03† 7.29 0.03 7.25  0.02 7.13  0.03†
Base excess, mmol/l 11.87  0.80 17.00  0.97 15.21  1.19 11.0  0.78 12.60  1.72 17.19  1.22‡
HCO3, mmol/l 15.6  1.2 10.9  2.0* 13.9  2.0 17.8  2.0 12.8  4.1* 12.8  4.7†
SO2, % 87.8  4.2 83.7  6.7 80.8  12.8 89.7  1.5 88  9.2 78.5  6.9
Glucose, mmol/l 12.6 3.6 4.8  1.0‡ 3.0  1.3‡ 13.2  3.5 3.2  1.4‡ 2.6  1.5‡
Lactate, mmol/l 3.8 0.7 2.6  0.4 4.6  1.2 3.9  0.0 1.6  0.6 3.2  1.0
Na, mmol/l 147.2  1.8 154.0  2.6† 149.3  2.7 147.6  2.4 152.5  2.7* 150.9  4.8
K, mmol/l 4.8  1.1 3.3  0.6 4.9  1.9 4.2  1.6 3.3  0.4 4.5  1.7
Cl, mmol/l 121.8  3.2 128.0  2.2 126.3  4.9 121.7  3.9 128.2  1.5* 129.1  5.7†
Hemoglobin, g/dl 11.3 1.1 9.8  0.7 10.4 1.8 11.4  2.2 8.6  1.6 10.6  2.3
Hematocrit, %PCV 32.6 1.1 26.25 2.6 30.57  1.4 33.43  2.0 26.0  1.9 30.25 2.1
Values are means  SE; n  3-16 mice. HCO3, bicarbonate; SO2, venous oxygen saturation; PCV, packed cell volume. *P  0.05, †P  0.01, and ‡P 
0.001 relative to sham/naive; and §P  0.001 relative to 6-h time point, one-way ANOVA and Bonferroni post hoc test. *18 mol/l cut-off value on iSTAT
device.
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Characterization of mesenteric perfusion by full-field laser
speckle contrast imaging. Assessment of mesenteric or subcu-
taneous ear blood flow was performed in situ under isoflurane
anesthesia and using a homeothermically controlled heating
mat coupled to a rectal temperature probe (Fig. 2A). Both core
temperature (Fig. 2B) and mesenteric blood flow remained
stable throughout the recording period, and for up to 60 min
(data not shown). The presence of a telemetry probe in the
flank of the mouse had no bearing on the flow values recorded.
LPS-treated mice exhibited a hypothermic phenotype at 6 h
that was partially reversed by 24 h. CLP-treated mice became
gradually, but less severely, hypothermic over 24 h. These
observations are consistent with previous reports (8, 10, 42).
In contrast to microcirculatory hemodynamics, which stabi-
lized between 9 and 24 h postsepsis (Fig. 1 and Table 2),
mesenteric blood flow continued to decline in a time-dependent
manner, in both models of sepsis and in all vessel orders (Fig.
2, D–F).
Systemic venous blood biochemistry. Consistent with im-
paired microcirculatory perfusion, blood pH was signifi-
cantly reduced in a time-dependent manner in both models
of sepsis. Similarly, creatinine and urea were markedly
elevated at 24 h post-LPS and -CLP compared with the 6-h
time point, indicating end organ dysfunction despite sys-
temic blood pressure and CO stabilization. The increase in
creatinine and urea levels observed here is of a similar
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magnitude to those reported previously both for LPS (9, 10)
and CLP (23, 49). Mice also became severely hypoglycemic
over the 24-h time period, indicative of metabolic distur-
bance similar to that observed in humans subjected to
experimental endotoxemia (48). Venous oxygen saturation
(SO2) did not change significantly over the course of sepsis
in either model, however. These data and all other blood
biochemistry are summarized in Table 3.
Effect of fluid resuscitation on microvascular and metabolic
function. Given the continued deterioration of mesenteric
blood flow over the 24-h period, compared with the apparent
preservation of macrocirculatory hemodynamics and global
SO2, we aimed to ascertain whether our technique for quanti-
fying microcirculatory blood flow was sensitive to fluid resus-
citation, a mainstay clinical intervention known to improve
microcirculatory perfusion, organ function, and survival in
patients (41) and septic mice (21).
This intervention modestly, but significantly, improved
perfusion in first-order mesenteric vessels (Fig. 3A), and a
similar pattern of improvement was observed in second- and
third-order vessels [mean area under the curve (	103 flux
units/time): 221  52 vs. 407  78 in second-order vessels,
nonsignificant; 141  334 vs. 343  44 in third-order
vessels, P  0.05]. Volume-resuscitated mice also exhibited
modest improvements in hypothermia (data not shown),
arbitrary severity score (based on posture, mobility, aver-
sion to touch, and piloerection, assigned in a blinded fash-
ion; Fig. 3B), metabolic acidosis (Fig. 3D), urea (Fig. 3E),
and lactate production (Fig. 3F). Interestingly, measurement
of perfusion by the same method in a different microvascu-
lar bed, the ear, revealed a significant decrease in blood flow
in CLP-treated mice that was also reversed by fluid resus-
citation (Fig. 3, C and G).
Intravenous bolus administration of norepinephrine, known
to raise MAP in endotoxic mice (39), did not improve mesen-
teric perfusion in LPS-treated mice. On the contrary, it caused
a marked and relatively sustained decrease in blood flow (Fig.
4, A–C). These data support the notion that improvement in
global hemodynamic parameters does not necessarily result in
improved regional perfusion, and that the pharmacological
activity of vasopressors, such as norepinephrine (
1-adreno-
ceptor-mediated smooth muscle constriction), may override the
physiological effect of increasing global oxygen delivery. Top-
ical administration of sodium nitroprusside, a vasodilator, on
the other hand, was found to reverse LPS-induced microvas-
cular impairment, in all order branches of the mesenteric
vascular tree (Fig. 4, D and E). These data suggest that active
vasoconstriction accounts, at least in part, for the reduced
mesenteric perfusion observed in sepsis and are consistent with
the effects of topical vasodilators applied to the sublingual
microvasculature in septic patients (13).
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DISCUSSION
The key findings from this study are as follows:
1) Laser speckle contrast imaging can be used in concert
with other standard hemodynamic techniques to robustly assess
microcirculatory perfusion in septic mice.
2) Microcirculatory flow, as quantified in the mesenteric
circulation, more closely correlates with end-organ perfusion
and metabolic disturbances in both sepsis models.
3) Stabilization of macrocirculatory hemodynamics (MAP
and CO) is likely to occur at the expense of microcirculatory
perfusion and is, therefore, insufficiently predictive of out-
come. Similarly, strategies aimed at elevating MAP pharma-
cologically may adversely affect microcirculatory perfusion.
4) Aggressive fluid resuscitation measurably improves mi-
crocirculatory perfusion and end-organ function, consistent
with clinical observations.
A strong research drive and extensive media coverage have
served to bring sepsis into public prominence in recent years.
A significant factor in the lack of effective treatments for septic
shock, in addition to the limitations of related clinical trials
(28), is the problem of research translatability; numerous
interventions that have proved beneficial in rodent models have
failed to translate into improved outcome in humans (38).
Patient and pathogen heterogeneity, and the confounding ef-
fects of clinical intervention, complicate the process of devel-
oping a relevant model in which to investigate disease mech-
anisms. Preclinical focus on end points with low prognostic
value, however, may also have contributed significantly to this
issue. While research has tended to center on global hemody-
namics and crude mortality end points, models that focus on
the mechanism of death, specifically perfusion failure, may be
more clinically relevant.
In this study, it is especially noteworthy that, in both
models, sepsis-induced hypotension and alterations in CO
and HR stabilized after 9 h, with values at 24 h equivalent
to those at 6 h postsepsis, despite a continued decline in
mesenteric perfusion. This suggests that systemic stabiliza-
tion may be preserved at the expense of the microcircula-
tion, as discussed previously (45), and as demonstrated
clearly in Fig. 5. Furthermore, while MAP and HR data
suggested that LPS-treated mice displayed marked cardio-
vascular dysfunction, the equivalent changes in CLP-treated
mice were relatively modest. In contrast, microcirculatory
perfusion in CLP-treated mice was markedly impaired and
continued to decline over the experimental time course,
correlating closely with clinically relevant markers of out-
come (i.e., metabolic acidosis and organ dysfunction).
Moreover, administration of norepinephrine, known to raise
arterial pressure and used clinically to restore hemodynam-
ics, actually diminished mesenteric perfusion, suggesting,
first, that prolonged vasopressor use may accelerate organ
failure, and, second, that treatment strategies targeted at
global hemodynamics may have limited efficacy, as demon-
strated previously (19). Furthermore, these data emphasize
the importance of titrating vasopressor doses carefully, to
limit the potential for detrimental effects on organ perfu-
sion.
Taken together, these observations highlight the importance
of measuring loco-regional perfusion directly, rather than using
global surrogates. Numerous studies have demonstrated that
restoration of global oxygen delivery does not necessarily
enhance regional perfusion (4, 16, 19, 26, 33). A potentially
large contributing factor in this “oxygen extraction deficit” is
the active constriction of compliant vascular beds (including
the gut) to elevate peripheral vascular resistance and arterial
pressure. This may account for the measurements of normal
mixed-venous SO2 levels, despite severe local tissue dysoxia,
as observed both in this study and in septic patients (24).
Consistent with this hypothesis, we have demonstrated a sig-
nificant increase in blood flow through regional administration
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Fig. 5. Representative blood pressure traces and corresponding mesenteric blood flow images from two LPS-treated mice. Blood pressure traces were collected
immediately before blood flow recording at 24 h post-LPS. Whereas mouse 1 exhibited compromised MAP and pulse pressure, mesenteric perfusion was less
severely disrupted relative to mouse 2, which exhibited a profound decrease in mesenteric perfusion, despite normal hemodynamics. This demonstrates that MAP
alone is insufficiently predictive of syndrome progression.
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of a vasodilatory agent, indicating that mesenteric flow disrup-
tion in sepsis comprises, at least in part, an active vasocon-
strictive component.
While acute arteriovenous shunting may be essential to
preserve global circulation and perfusion of heart and brain
tissue in acute hypovolemia, prolonged microcirculatory shut-
down, most notably in the splanchnic region, inevitably leads
to hypoxic tissue injury and the development of organ failure
(45, 47). Clinically described as “the motor of multiple organ
failure” (7), the gut represents an important microcirculatory
bed in septic shock, where impaired flow is known to correlate
strongly with poor outcome both in animal models (3) and
sepsis patients (45, 47). This likely reflects the fact that
impaired perfusion of the intestine, and associated hyperper-
meability, facilitates the leakage of microorganisms and endo-
toxin from the gut lumen into the lymphatic and cardiovascular
circulation, exacerbating the inflammatory state (44).
Correspondingly, our data emphasize that stabilization of
macrocirculatory parameters may not indicate halting of syn-
drome progression and, therefore, should not be used as a
prognostic marker in isolation. This conclusion is supported by
clinical evidence: numerous trials of interventions that improve
hemodynamic performance in animal models (11, 47) and
humans have failed to confer a survival benefit in clinical trials
(20, 31, 34). We have demonstrated that direct measurement of
mesenteric perfusion, known to confer high prognostic value in
the clinic (20, 25, 37), is not only feasible in a murine model,
it is also more sensitive to syndrome progression.
Because murine models facilitate gene modification, they
currently represent the only viable option for conducting mech-
anistic preclinical proof-of-concept research. Therefore, the
authors consider it of paramount importance to optimize the
systems available to us by limiting confounding influences, and
to employ animal models to their full capacity, extracting as
much information as possible from a single individual. We
have demonstrated that a number of biological measurements
can be performed in a single mouse (as shown schematically in
Fig. 6) without compromising data quality or reproducibility,
and without incurring undue suffering, which can lead to
stress-induced artifacts.
This novel application of laser speckle contrast imaging
technology enables real-time, in situ visualization of blood
flow across the entire mesenteric bed, with no dissection of
perivascular tissue and minimal mechanical disruption to the
vessels. This represents a significant advantage over traditional
laser Doppler techniques that are usually limited to measure-
ments in single vessels, often requiring extensive microdissec-
tion and probe-tissue contact, with significantly lower process-
ing speeds. Additionally, this technique does not require the
use of fluorescent dyes necessary for intravital microscopy.
Furthermore, it allows quantification of flow within specified
regions of interest, both at baseline and following topical or
intravenous administration of a pharmacological agent. As
such, the model represents a practical substitute to the side-
stream dark-field imaging technique that is used clinically,
while circumventing the need for high-level operating exper-
tise, as well as interoperator variability and probe-tissue con-
tact artifacts.
Measurement of blood flow in the ear may represent a less
invasive method for repeated-measures testing of microcircu-
latory function over a specific time course, given that it does
not require terminal anesthesia, although further validation in
A B C D
H G F E
sepsis
Fig. 6. Schematic representation of multiparameter monitoring of sepsis progression in a single mouse. Following implantation of telemetry catheters (A), baseline
hemodynamics are recorded remotely in unrestrained ambulatory mice (B). Basal cardiac function is measured under isoflurane anesthesia by echocardiography
(C). Sepsis is then induced either by LPS or CLP (D), and hemodynamics (E) and cardiac function (F) are re-recorded in the same mice under pathological
conditions. Mice are then terminally anesthetized at a time point of interest, and mesenteric blood flow is measured by laser speckle contrast imaging (G).
Intravenous or topical drug administration may be used to determine vasoactivity. Mice are then terminated by venupuncture, and blood samples obtained from
the inferior vena cava are analyzed by iSTAT point-of-care analyzer (H). Further biochemical and histological investigation may then be carried out.
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this bed is required. The observed improvement in perfusion
and organ function in response to fluid resuscitation suggest
that this model is clinically relevant and may be adapted to a
comparatively hyperdynamic murine model of sepsis (21).
Furthermore, the model is not limited to sepsis research, but
has wider applications for in situ investigation of thrombosis or
in situ vasoactivity (32).
In summary, we demonstrate that microcirculatory perfusion
more closely correlates with end-organ damage (the ultimate
cause of death in sepsis patients) and that macrocirculatory
hemodynamics alone may have limited prognostic value. We
believe that quantification of microcirculatory blood flow, as
described, provides a more humane end point, while simulta-
neously improving the clinical translatability of preclinical
sepsis studies.
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